Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GEB - Genetronics Biomedical -- Ignore unavailable to you. Want to Upgrade?

To: MAX LLOYD who wrote (1)	4/23/1999 9:10:00 AM
From: Dan Hamilton	Read Replies (1) \| Respond to of 31

I have recently stumbled on this one too. I haven't bought yet though...I want to do some DD. Here's a short blurb on them GEB develops, manufactures, and markets electroporation instrumentation and accessories used to perform genetic engineering techniques, such as cell fusion, gene transfer, cell membrane research and genetic mapping. For the 6 months ended 9/30/98 (vs. 8/97), total revenues rose 19% to $2M. Net loss rose 63% to $5M. Revenues reflect increased product sales and collaborative research. Higher loss reflects higher R&D and S/G/A expenses.